Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia
暂无分享,去创建一个
D. Rossi | G. Gaidano | F. Pozzo | A. Zamó | A. Colombatti | E. Pivetta | P. Spessotto | R. Doliana | A. Capuano | V. Gattei | R. Boldorini | E. Tissino | A. Zucchetto | F. Rossi | T. Hartmann | D. Benedetti | R. Bomben | C. Caldana | Guido Capasso
[1] D. Rossi,et al. CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression. , 2020, Blood.
[2] F. Bucciotti,et al. Integrin binding site within the gC1q domain orchestrates EMILIN-1-induced lymphangiogenesis. , 2019, Matrix biology : journal of the International Society for Matrix Biology.
[3] V. Gattei,et al. Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical Applications. , 2018, Methods in molecular biology.
[4] A. Drzezga,et al. Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18 , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] T. Shanafelt,et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia , 2018, The Journal of experimental medicine.
[6] Pier Andrea Nicolosi,et al. The α4β1/EMILIN1 interaction discloses a novel and unique integrin-ligand type of engagement. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[7] R. Bernardi,et al. Reactivating nuclear PTEN to treat CLL , 2017, Oncotarget.
[8] P. Pandolfi,et al. Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones , 2017, Oncotarget.
[9] F. Bucciotti,et al. Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity , 2017, Scientific Reports.
[10] L. Liotta,et al. Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? , 2016, Leukemia.
[11] D. Rossi,et al. CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia , 2015, Leukemia.
[12] A. Wiestner,et al. Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo , 2015, Clinical Cancer Research.
[13] D. Weisenburger,et al. Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease , 2014, Molecular medicine.
[14] T. Shanafelt,et al. CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] V. Canzonieri,et al. Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[16] Carla Danussi,et al. EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance , 2013, Molecular and Cellular Biology.
[17] J. Byrd,et al. The B-cell receptor signaling pathway as a therapeutic target in CLL. , 2012, Blood.
[18] G. Gaidano,et al. Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy. , 2012, Current pharmaceutical design.
[19] Carla Danussi,et al. An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node Invasion , 2012, Cancer Prevention Research.
[20] C. Geest,et al. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia. , 2012, Blood.
[21] S. Volinia,et al. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes , 2012, Leukemia.
[22] D. Rossi,et al. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells , 2012, Leukemia.
[23] Carla Danussi,et al. EMILIN1–α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation , 2011, The Journal of cell biology.
[24] D. Rossi,et al. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. , 2009, Cancer research.
[25] I. Campbell,et al. The Solution Structure of EMILIN1 Globular C1q Domain Reveals a Disordered Insertion Necessary for Interaction with the α4β1 Integrin* , 2008, Journal of Biological Chemistry.
[26] Michael Hallek,et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.
[27] Carla Danussi,et al. Vasculature Functional Defects of Lymphatic Deficiency Causes Structural and Emilin1 , 2008 .
[28] T. Shanafelt,et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential , 2008, British journal of haematology.
[29] F. Buccisano,et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. , 2008, Blood.
[30] Giada Monamì,et al. EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall , 2006, Journal of Cell Science.
[31] S. Dupont,et al. Emilin1 Links TGF-β Maturation to Blood Pressure Homeostasis , 2006, Cell.
[32] P. Braghetta,et al. EMILIN-1 Deficiency Induces Elastogenesis and Vascular Cell Defects , 2004, Molecular and Cellular Biology.
[33] A. Colombatti,et al. β1 Integrin-dependent Cell Adhesion to EMILIN-1 Is Mediated by the gC1q Domain* , 2003, The Journal of Biological Chemistry.
[34] A. García-Pardo,et al. Adhesion to fibronectin via α4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo‐1 receptors , 2002, Clinical and experimental immunology.
[35] A. García-Pardo,et al. Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax , 1999, Leukemia.
[36] P. Circosta,et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. , 1999, Leukemia research.
[37] D. Catovsky,et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.
[38] A. Colombatti,et al. Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface , 1993, The Journal of cell biology.
[39] M. A. O. Ignacio,et al. How to cite this article , 2016 .
[40] P. E. Van den Steen,et al. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. , 2014, Journal of leukocyte biology.
[41] M. T. de la Fuente,et al. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. , 2002, Journal of leukocyte biology.